Hypothesis

The age‑related decline of hypothalamic neural stem cells (NSCs) removes a critical source of exosomal microRNAs that constitutively inhibit microglial IKKβ/NF‑κB signaling. When these NSC‑derived exosomes are lost, microglia experience unchecked Toll‑like receptor (TLR) adaptor activation, leading to IKKβ‑mediated NF‑κB nuclear translocation in GnRH neurons, transcriptional repression of GnRH, and the downstream systemic aging phenotype. Restoring NSC exosomes or their specific miRNA cargo should block microglial IKKβ activation, preserve GnRH expression, and attenuate aging phenotypes.

Mechanistic Basis

1. NSC exosomes deliver miR‑146a‑5p and miR‑124‑3p – both miRNAs have been shown to target key adapters of the MyD88/TRIF pathways (IRAK1, TRAF6) and to suppress NF‑κB activation in microglia (Nature 2013 exosomal miRNA).

2. Aging NSC loss reduces exosomal miRNA flux – the same study reported a progressive drop in NSC number and exosomal output correlating with onset of aging signs.

3. Microglial IKKβ/NF‑κB drives GnRH repression – IKKβ phosphorylates IκB, allowing RelA/p65 to bind the GnRH promoter and recruit c‑Fos/c‑Jun and PKCα/δ, cutting promoter activity by ~50% ( 2013).

4. Restoration of NSC exosomes rescues GnRH – exogenous NSC exosomes have reversed neuroinflammatory markers in other brain regions (Stem Cell Reports 2020).

Testable Predictions

• Prediction 1: In aged mice, intracerebroventricular delivery of purified NSC exosomes will decrease microglial p‑IKKβ levels (immunohistochemistry) and increase GnRH mRNA expression in the mediobasal hypothalamus by ≥30% compared with vehicle‑treated controls.

• Prediction 2: Antagomir‑mediated inhibition of miR‑146a‑5p or miR‑124‑3p in young mice will phenocopy the aging signature: elevated microglial NF‑κB activity, reduced GnRH, and early onset of peripheral aging markers (skin thickness, bone density, circulating IGF‑1).

• Prediction 3: GnRH‑neuron‑specific IKKβ knockout mice will be resistant to the pro‑aging effects of NSC exosome depletion, demonstrating that the NSC‑exosome → microglia → IKKβ → GnRH axis is necessary for the phenotype.

Experimental Approach

1. Isolate NSCs from young (3‑month) and old (24‑month) mice, collect exosomes by ultracentrifugation, validate miR‑146a‑5p and miR‑124‑3p enrichment by qPCR.

2. Treat aged mice with biweekly icv injections of NSC exosomes (or PBS control) for 8 weeks.

3. Measure: microglial p‑IKKβ (Iba1/p‑IKKβ co‑staining), nuclear RelA in GnRH neurons (immunofluorescence), GnRH transcript (RT‑qPCR), LH pulsatility, and systemic aging readouts (frailty index, telomere length in liver).

4. Parallel groups receive NSC exosomes depleted of miR‑146a‑5p/miR‑124‑3p via antisense oligos loaded into exosomes to confirm miRNA dependence.

Falsifiability

If NSC exosome replacement fails to lower microglial IKKβ activation or to raise GnRH levels despite confirmed delivery, or if miRNA inhibition does not accelerate aging phenotypes, the hypothesis would be refuted. Conversely, a positive result would support the model that NSC‑derived exosomal miRNAs act as an upstream brake on microglial IKKβ/NF‑κB, linking stem cell loss to neuroendocrine aging.